Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2009 Filed Feb 20, 2009 01:57 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 2,629 | $54.94 | $144,437.26 |
DisclosureSEC source: 0001104659-09-010841 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,292 Read SEC document |
| February 17, 2009 Filed Mar 27, 2009 21:24 UTC Amendment |
Warmuth Michael JSenior Vice President
|
Tax withholdingCommon shares without par value | 285 | $54.94 | $15,657.90 |
DisclosureSEC source: 0001104659-09-020993 · a4a.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,346 F1 · shares: The reporting person's Form 4 filed on February 19, 2009, did not report the withholding of 285 shares to satisfy the reporting person's tax obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:35 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 6,057 | $0.00 Strike: $57.15 | $0.00 |
DisclosureSEC source: 0001104659-09-008433 · a4.xml · derivative · entry 8 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,057 Underlying: Common shares · 6,057 shares Expires 2011-02-08 F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:35 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,998 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-008433 · a4.xml · derivative · entry 7 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,526 Underlying: Common shares · 4,998 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:35 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-008433 · a4.xml · derivative · entry 6 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:35 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 6,057 | $57.15 | $346,157.55 |
DisclosureSEC source: 0001104659-09-008433 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,260 Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:35 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 7,198 | $45.45 | $327,140.46 |
DisclosureSEC source: 0001104659-09-008433 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,758 | $0.00 Strike: $56.85 | $0.00 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,758 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,143 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 8,143 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,758 | $57.00 | $100,206.00 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,437 Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 8,143 | $56.99 | $464,069.57 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,195 Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 1,758 | $56.85 | $99,942.30 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2009 Filed Feb 12, 2009 00:43 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 8,143 | $56.30 | $458,450.90 |
DisclosureSEC source: 0001104659-09-008434 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 00:48 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 100 | $57.03 | $5,703.00 |
DisclosureSEC source: 0001104659-09-008065 · a4.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,142 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 00:48 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 2,500 | $57.02 | $142,550.00 |
DisclosureSEC source: 0001104659-09-008065 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,242 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 00:48 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 3,900 | $57.01 | $222,339.00 |
DisclosureSEC source: 0001104659-09-008065 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,742 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 00:48 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 31,200 | $57.00 | $1,778,400.00 |
DisclosureSEC source: 0001104659-09-008065 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,642 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,792 | $0.00 Strike: $56.53 | $0.00 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · derivative · entry 10 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,792 Underlying: Common shares · 1,792 shares Expires 2013-02-13 F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOptions (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · derivative · entry 9 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOptions (right to buy) · Derivative | 1,840 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · derivative · entry 8 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,840 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 1,792 | $56.53 | $101,301.76 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · nonDerivative · entry 4 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,119 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,050 | $33.23 | $101,355.77 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · nonDerivative · entry 3 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
SaleCommon shares without par value | 1,840 | $57.00 | $104,883.68 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,861 Read SEC document |
| February 06, 2009 Filed Feb 11, 2009 01:26 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,840 | $54.30 | $99,912.00 |
DisclosureSEC source: 0001104659-09-008066 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,808 | $0.00 Strike: $56.34 | $0.00 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 11,808 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 11,808 | $56.44 | $666,443.52 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,427 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 11,808 | $56.34 | $665,262.72 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:01 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,445 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-007338 · a4.xml · derivative · entry 4 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,445 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:01 UTC |
Szela Mary TSenior Vice President
|
Tax withholdingCommon shares without par value | 2,996 | $56.98 | $170,712.08 |
DisclosureSEC source: 0001104659-09-007338 · a4.xml · nonDerivative · entry 2 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,100 Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:01 UTC |
Szela Mary TSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,445 | $45.45 | $156,571.12 |
DisclosureSEC source: 0001104659-09-007338 · a4.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:40 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value · Derivative | 20,882 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-09-007371 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 20,882 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:40 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 19,778 | $56.98 | $1,126,950.44 |
DisclosureSEC source: 0001104659-09-007371 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,837 Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 22:40 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 20,882 | $52.55 | $1,097,349.10 |
DisclosureSEC source: 0001104659-09-007371 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:19 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,754 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001104659-09-007380 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,754 Underlying: Common Shares · 1,754 shares Expires 2011-02-08 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:19 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,200 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-007380 · a4.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,200 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:19 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 1,754 | $56.98 | $99,942.92 |
DisclosureSEC source: 0001104659-09-007380 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,921 Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:19 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,200 | $45.45 | $99,987.36 |
DisclosureSEC source: 0001104659-09-007380 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
GrantOption (right to buy) · Derivative | 894 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894 Underlying: Common shares · 894 shares Expires 2011-02-08 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,028 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,028 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 894 | $56.98 | $50,940.12 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,909 Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:43 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 1,028 | $45.45 | $46,721.37 |
DisclosureSEC source: 0001104659-09-007393 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 881 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 881 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 281 | $56.24 | $15,804.00 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,427 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 600 | $56.25 | $33,752.40 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,708 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 881 | $53.60 | $47,221.60 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 01:38 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,811 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006944 · a4.xml · derivative · entry 20 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811 Underlying: Common Shares · 1,811 shares Expires 2014-02-19 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 01:38 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,823 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006944 · a4.xml · derivative · entry 19 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common Shares · 1,823 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 01:38 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,798 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006944 · a4.xml · derivative · entry 18 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,798 Underlying: Common Shares · 1,798 shares Expires 2010-02-10 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 01:38 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,454 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-09-006944 · a4.xml · derivative · entry 17 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,454 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 01:38 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-09-006944 · a4.xml · derivative · entry 16 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.